Study of XL647 Administered Orally Daily to Patients With Solid Tumors

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Kadmon Corporation, LLC
ClinicalTrials.gov Identifier:
NCT00336765
First received: June 12, 2006
Last updated: October 17, 2011
Last verified: October 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2010
  Primary Completion Date: August 2010 (Final data collection date for primary outcome measure)